Your mention of the ongoing investigations in 'in vivo' treatments, is particularly interesting. Regarding the current status of these 'in vivo' treatments, are there any specific trials or research projects that have caught your attention or that you're particularly excited about? It would be great to hear more about any promising developments in this area as well.
We are neighbors with Umoja here in Seattle, so I’ve been following their progress for awhile. A few of the other co’s include: Capstan, Kelonia and Exuma. Still early days for majority here, but Umoja says they will enter the clinic this year. Exuma presented some data at AACR last year. Hopefully more clinical data is generated soon for this modality!
Your mention of the ongoing investigations in 'in vivo' treatments, is particularly interesting. Regarding the current status of these 'in vivo' treatments, are there any specific trials or research projects that have caught your attention or that you're particularly excited about? It would be great to hear more about any promising developments in this area as well.
We are neighbors with Umoja here in Seattle, so I’ve been following their progress for awhile. A few of the other co’s include: Capstan, Kelonia and Exuma. Still early days for majority here, but Umoja says they will enter the clinic this year. Exuma presented some data at AACR last year. Hopefully more clinical data is generated soon for this modality!
Thanks for the update, I'll check these out. Very exciting work!